Michael Rapp - 02 Oct 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/Michael Rapp
Issuer symbol
IMNM
Transactions as of
02 Oct 2023
Net transactions value
+$1,499,993
Form type
4
Filing time
03 Oct 2023, 17:50:48 UTC
Previous filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Award $1,499,993 +253,806 +31% $5.91 1,071,172 02 Oct 2023 Direct F1
holding IMNM Common Stock 208,742 02 Oct 2023 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Michael Rapp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares were issued to the Reporting Person pursuant to the closing of the transactions contemplated by that certain Subscription Agreement, dated as of June 29, 2023, by and among the Reporting Person and the Issuer and in connection with the closing of to the transactions contemplated by that certain Agreement and Plan of Merger and Reorganization, dated as of June 29, 2023, by and among the Issuer, Morphimmune Inc., a Delaware corporation, and Ibiza Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer.
F2 The shares are held by Broadband Capital Investments LLC ("Broadband"). The reporting person is managing member of Broadband and has voting and investment power with respect to shares held by Broadband.